NEWS: APRIL 2003

-4/30/2003-

SciQuest Inc. launches its SelectSite® procurement automation solutions. To read article click here. SciQuest provides software applications for R&D including the Analytical Chemical Manager (ACM) for combinatorial chemistry analytical data tracking and handling. For a review on SciQuest's Analytical Chemical Manager (ACM) here at CombiChem Lab click here.

Pfizer Inc. to close three R&D facilities with 2,000 employees: South San Francisco (California) Skokie (Illinois) and Fresnes (France). No decision on number of leyoffs yet. To read article click here.

Thios Pharmaceuticals Inc. receives SBIR grant from the NIH to develop novel antibodies for the treatment of chronic inflammatory diseases such as asthma and rheumatoid arthritis. To read article click here.

CyDex Inc. to license CAPTISOL® to Teva Pharmaceutical Industries Ltd. To read article click here.

Biomira Inc. expands coverage of its U.S. patent 5,798,090 for the use of carbohydrate vaccine formulations in cancer therapy. To read article click here.

Cutting Edge Information has available new report: "Blockbuster Pharmaceutical Launches: Marketing Spend and Structure." To read article click here. To find this report click here.

Teva Pharmaceutical Industries Ltd. and GlaxoSmithKline settle dispute on the non-steroidal anti-inflammatory drug (NSAID) Nabumetone. To read article click here.

CytRx Corporation and the University of Massachusetts Medical School expand RNA interference (RNAi) research collaboration for drug development for treatment of obesity and type II diabetes. To read article click here.

Researchers at Case Western Reserve University develop fusion imaging technique to monitor prostate cancer as well to guide both surgery and radiation therapy. To read article click here.

Cellomics Inc. and the Mayo Clinic and Foundation form collaboration for High Content Screening research facility. To read article click here.

-4/29/2003-

Press Release: Used by hundreds of HazMat teams, Weapons of Mass Destruction inspectors, Police & Fire officers and Chemical Engineers worldwide the TravelIR from SensIR Technologies has become a defacto standard item of equipment for first response chemical identification. To read press release click here.

IBC to host the "8th Annual Drug Discovery Technology™ World Congress" conferences on August 10-15, 2003, in Boston, MA. For more information on this conference click here. IBC promotes and hosts a broad range of scientific oriented conferences. For more information on IBC here at CombiChem Lab click here.

MDL Information Systems Inc. to provide UCB Pharma with next-generation discovery informatics technology for its drug discovery research. To read article click here. MDL provides software and databases for combinatorial chemistry, drug discovery and HTS. For a review of MDL's software for combinatorial chemistry here at CombiChem Lab click here.

Johnson & Johnson acquires Scios Inc. for $2.4 billion. To read article click here.

Pfizer Inc. to close five research sites over the next 18 months as a result of the acquisition of Pharmacia Corp. To read article click here.

Novitron International Inc. acquires all the assets of Elan Diagnostics Inc. To read article click here.

Cytorex Biosciences Inc. developes inorganic acids for treatment of cancer and immunology related diseases. To read article click here.

Neose Technologies Inc. licenses to GlaxoSmithKline exclusive license to develop and commercialize certain human vaccines. To read article click here.

ImClone Systems Inc.'s CEO and also its chairman resign. To read article click here.

Locus Pharmaceuticals Inc and Speedel Group form research collaboration for novel renin inhibitors. To read article click here.

-4/28/2003-

Press Release: Scitegic releases Pipeline Pilot V3.0 for enterprise use. To read press release click here.

The Strategic Research Institute (SRI) will host the "Metabolic Diseases Drug Discovery World Summit" conference on July 28-29, 2003, in San Diego, CA. To read article click here. SRI promotes and hosts a broad range of scientific oriented conferences. For more information on SRI here at CombiChem Lab click here.

Scios Inc. shareholders approve merger with Johnson & Johnson. To read article click here.

Clinimetrics expands its Corporate Headquarters. To read article click here.

Syngenta AG will not start first trials of its genetically modified wheat after sabotage. To read article click here.

FDA turns down Noven Pharmaceuticals Inc.'s new drug application (NDA) for its MethyPatch® for attention deficit hyperactivity disorder (ADHD) treatment. To read article click here.

Pro-Pharmaceuticals Inc. receives US patent allowance for its patent application entitled "Methods and Compositions for Reducing Side Effects in Chemotherapeutic Treatments." To read article click here.

4SC AG and ProQinase GmbH form kinase research collaboration to identify protein kinase inhibitors for cancer treatment. To read article click here.

-4/25/2003-

Press Release: Genevac Ltd, world leader in solvent removal for drug discovery applications, has announced the introduction of a new sample rack compatible with Gilson fraction collector beds. To read press release click here. Genevac Ltd. provides high-throughput centrifugal evaporation systems for combinatorial chemistry, high-throughput screening (HTS) and drug discovery. To read a review of Genevac's systems here at CombiChem Lab click here. Gison Inc. provides liquid handlers for combinatorial chemistry sysnthesis and high-throughput analytical systems. For a review on Gilson's liquid handlers here at CombiChem Lab click here.

Press Release: For labs with sterilisation and sample heating applications requiring precision, flexibility and high operational safety the FIREBOY range of mobile Bunsen burners from INTEGRA Biosciences provide the perfect solution. To read press release click here.

Merck & Co. Inc. to stop development of Phosphodiesterase-4 (PDE-4) inhibitor compound licensed from Celltech for asthma and chronic obstructive pulmonary disease (COPD) due to colitis development in a Phase II trial patient. To read article click here.

Bayer AG still looking for partner for its pharmaceutical unit. To read article click here.

AstraZeneca's drug Faslodex approved for breast cancer in the United States. To read article click here.

-4/24/2003-

Press Release: On stand B26 Genetix will introduce and have available for demonstration the QArraymini spotter and aQuire scanner systems. To read press release click here.

Press Release: INTEGRA Biosciences has announced the new VACUSAFE™ comfort a compact next generation vacuum system designed to work with critical and hazardous substances. To read press release click here.

Pfizer Inc. to layoff workers in June at four New Jersey administrative and sales offices of former Pharmacia Corp. To read article click here.

Axonyx Inc. reaches milestone payment in collaboration with Serono S.A. for beta-sheet breaker peptide for Alzheimer's disease treatment. To read article click here.

Bristol-Myers Squibb Co. settles Taxol lawsuit for $55 million. To read article click here.

Bayer Polymers LLC and PolyOne Corporation form new venture: BayOne Urethane Systems, LLC. To read article click here.

FDA approves Genzyme Corp.'s Fabrazyme® (agalsidase beta) for Fabry disease. To read article click here.

Korvis Automation Inc. and Myriad Genetics form collaboration to create new ultra small volume liquid handling instrument. To read article click here.

-4/23/2003-

Press Release: Guava Technologies Inc, a leading provider of bench-top cellular analysis systems, has today announced a breakthrough in accurate and rapid high-throughput screening of cell lines and compounds. To read press release click here.

Press Release: Specialising in the development and manufacture of innovative products that set new standards in the automation of time consuming and technical Genomic applications, Genetix Ltd. supplied colony picking systems that were key workhorses behind the effort to sequence the Human Genome. To read press release click here.

Agilent Technologies and North Carolina State University form microarray development collaboration for rice disease research. To read article click here. Agilent Technologies provides high-throughput HPLC analytical systems for combinatorial chemistry and drug discovery. For a review of Agilent's analytical systems here at CombiChem Lab click here.

Schering-Plough Corp. to acquire the U.S. distribution and marketing rights to Dariclox, Amoxi-Mast and Orbenin-DC from Pfizer Inc. To read article click here.

Allos Therapeutics Inc.'s anti-cancer drug RSR13 fails clinical trials. To read article click here.

Father of a former Sepracor Inc. accounting manager pleads guilty to insider trading charges. To read article click here.

Molecular NeuroImaging LLC launches discovery unit for the rational development of drug candidates for neuropsychiatric disorders. To read article click here.

Researchers at BioMarker Pharmaceuticals find diabetes drug Metformin has anti-aging effects. To read article click here.

Texas Biotechnology Corp. pays about $10 million to acquire 50% of ICOS Corp.'s interest in their ICOS-Texas Biotechnology L.P. venture. To read article click here.

Iconix Pharmaceuticals Inc. to license exclusive rights to new data mining tools for experiments in predictive chemogenomics from University of California at Berkeley. To read article click here.

CombiMatrix to provide its new SARS (Severe Acute Respiratory Syndrome) microarrays at no cost to key government and academic researchers. To read article click here.

ViroLogic Inc. identifies HIV drug resistance for lopinavir and amprenavir at the gene level. To read article click here.

-4/22/2003-

Aventis Pharmaceuticals Inc. to terminate technology transfer agreement with Millennium Pharmaceuticals Inc. To read article click here.

Merck & Co. Inc. to spin off Medco Health Solutions Inc. To read article click here.

Chiron Corporation acquires exclusive worldwide development and commercial rights from Novartis for aerosolized cyclosporine (ACsA). To read article click here.

Serenex Inc. and MolecularNature Ltd form collaboration to screen MolecularNature's plant-derived compounds using Serenex's chemoproteomic and Proteome Mining™ technologies. To read article click here.

Doblique Inc. to acquire INyX Pharma Limited. To read article click here.

Lexicon Genetics Incorporated licenses gene targeting technologies non-exclusive rights to Aventis Pharmaceuticals Inc. To read article click here.

Human Genome Mapping Project licenses Silicon Genetics' GeNet system. To read article click here.

-4/21/2003-

Scientists complete Human Genome sequence. To read article click here.

Press Release: Porvair Sciences Ltd., in conjunction with German partner Zinsser Analytic GmbH has announced their presence at Achema 2003 in Frankfurt, Germany (19-24th May 2003) with the latest additions to its portfolio of cutting edge microplate technology for high-throughput applications. To read press release click here. Zinsser Analytic offers a broad line of workstations with liquid handling capabilities for combinatorial chemistry and drug discovery. For a review of Zinsser Analytic systems here at CombiChem Lab click here.

Press Release: With 20 years experience in HPLC techniques, ESA Services offers method development, validation and analysis of actives and surrogates through its sister company, ESA Analytical, based in the UK. To read press release click here.

Press Release: A new technical datasheet from Porvair Sciences is now available detailing their comprehensive range of high quality 96 and 384-well Assay microplates. To read press release click here.

Press Release: At MipTec 2003 to be held in Basel Switzerland from 12th -15th May, Porvair Sciences Ltd. will showcase a series of its latest products to the assembled audience of leading life scientists. To read press release click here.

The Strategic Research Institute (SRI) will host the "Biomarkers and Their Application in the Acceleration of Drug Development Process" conference on July 14-15, 2003, in Philadelphia, PA. To read article click here. SRI promotes and hosts a broad range of scientific oriented conferences. For more information on SRI here at CombiChem Lab click here.

Tripos Inc.'s United Kingdom-based discovery research operation Tripos Receptor Research Ltd. (TRR) receives 2003 Queen's Award for Enterprise in Innovation. To read article click here. Tripos Inc. provides a suite of software tools for combinatorial chemistry and drug discovery. For a review of Tripos' software tools here at CombiChem Lab click here.

Lawsuit filed against King Pharmaceuticals Inc. for allegedly misleading investors. To read article click here.

The Colorectal Cancer Information Network is launched. To read article click here.

Isis Pharmaceuticals Inc. reaches milestone in Eli Lilly & Co. research collaboration with the development of potential antisense cancer agent ISIS 23722. To read article click here.

CytRx Corporation and the University of Massachusetts Medical School sign exclusive license agreements to develope new active compounds using RNAi technology for several disease areas such as obesity, diabetes II and cancer. To read article click here.

Pure Protein L.L.C. licenses 3 Hepatitis C transfected cell lines from NIH to initiate Hepatitis C vaccine discovery project. To read article click here.

Novartis AG subscribes to Gene Logic Inc.'s ToxExpress® Predictive System. To read article click here.

Structural GenomiX Inc. and Eli Lilly and Company form research collaboration to determine Eli Lilly's 3-D traget structures. To read article click here.

-4/14/2003 to 4/20/2003-

Due to a personal reasons CombiChem Lab will not be updated during the 3rd week of April 2003. CombiChem Lab is expected to be actively updated again on April 21, 2003. Thank you for understanding and for visiting CombiChem Lab. -Guillermo A. Morales

-4/11/2003-

Press Release: Tecan (UK) has announced a data sheet describing a new Protein Crystallography Workstation that automates the traditionally cumbersome tasks involved with preparing protein crystals. To read press release click here. Tecan provides the ChemSystem workstation and the TECAN MiniPrep systems for combinatorial chemistry and drug discovery. To read a review of TECAN's systems here at CombiChem Lab click here.

Press Release: Tecan (UK), a leading player in the Life Sciences supply industry, has introduced Aquarius, an automated multi-channel pipetting system that makes optimal use of laboratory space. To read press release click here. Tecan provides the ChemSystem workstation and the TECAN MiniPrep systems for combinatorial chemistry and drug discovery. To read a review of TECAN's systems here at CombiChem Lab click here.

Dyax Corp. and Corvas announce discovery of fully human monoclonal antibodies against endothelial serine proteases. To read article click here. Biotage Inc., a division of Dyax Corp., has a broad variety of purification systems for drug discovery. To find a review of Biotage's purification systems here at CombiChem Lab click here.

Former Gillette Co. executive Gino DeLuca is indicted for receiving nearly $600,000 in kickbacks. To read article click here.

Neurocrine Biosciences Inc. receives U.S. patent for stable polymorph of Indiplon for insomnia treatment. To read article click here.

StemCells Inc. presents proof-of-concept data for the use of human neural stem cells in Neuronal Ceroid Lipofuscinosis (Batten Disease). To read article click here.

Roche Holding AG receives FDA clearence for improved HIV test. To read article click here.

After bidding war Celltech PLC is clear to acquire Oxford GlycoSciences PLC for around GBP100 million in cash. To read article click here.

-4/10/2003-

Press Release: Available from SensIR Europe, the DuraScope™ is an in-compartment FT-IR accessory that unites the imaging capabilities of video microscopy with the versatility and simplicity of diamond ATR infrared analysis. To read press release click here.

Press Release: IMiX GmbH (Reinach, Switzerland) has announced a new version of their compact Katana Lab robot configured and programmed to automate the loading and unloading of any centrifuge system. To read press release click here.

Xoma Ltd. to receive $95 million in loans from Genentech Inc. To read article click here.

Deltagen Inc. to cut another 50 jobs. To read article click here.

Mylan Laboratories Inc. will relocate its corporate headquarters to Canonsburg, Pennsylvania. To read article click here.

Drug combination study of OSI Pharmaceuticals Inc.'s anti-cancer drug Tarceva, which is developed in conjunction with Genentech Inc., is stopped for safety reasons. To read article click here.

Schering-Plough Corp. and Novartis AG form collaboration to co-develop and ASMANEX® (mometasone furoate) and FORADIL® (formoterol fumarate) combined product for asthma and chronic obstructive pulmonary disease treatment. To read article click here.

Nanogen Inc. to cut 20 percent of its work force. To read article click here.

Nanogen Inc. launches 3 new products for gene mutation detection. To read article click here.

Evotec OAI and Novartis Pharma AG form lead discovery collaboration. To read article click here.

Memorial Sloan-Kettering Cancer Center, North General Hospital, and Polo Ralph Lauren to open Cancer Center in Harlem. To read article click here.

Telik Inc. and Roche form drug discovery collaboration using Telik's TRAP technology for drug candidate identification. To read article click here.

-4/09/2003-

ImClone Systems Inc.'s stock subject to deslisting from Nadsaq for not filling documents on unpaid taxes. To read article click here.

Gilead Sciences Inc.'s study of Hepsera for chronic hepatitis B treatment indicates the drug suppresses viral replication. To read article click here.

Researchers at University College London publish in New England Journal of Medicine link of protein ABCB1 to epilepsy drug resistance. To read article click here.

Telik Inc. identifies novel small molecule inhibitors for cancer targets (PARG, beta-1 integrin-mediated cell adhesion, hiCE, and Raf kinase) using its TRAP drug discovery technology. To read article click here.

Advancis Pharmaceutical Corp. receives U.S. patents entitled "Antibiotic Product, Use and Formulation Thereof" and "Antiviral Product, Use and Formulation Thereof." To read article click here.

Achillion Pharmaceuticals Inc. and Entomed SA from anti-viral drug discovery collaboration. To read article click here.

Borean Pharma A/S appoints Dr. Riku Rautsola as President and CEO. To read article click here.

Roche Holding AG's hepatitis C drug Pegasys found to be twice as effective compared to interferon therapy in patients with chronic hepatitis B in Phase II clinical trials. To read article click here.

Curis Inc. receives U.S. patent for novel anti-cancer drug candidates. To read article click here.

Inflazyme Pharmaceuticals Ltd. to acquire GlycoDesign Inc. To read article click here.

Cell Therapeutics Inc. discloses data on LPAAT-beta as a novel cancer target. To read article click here.

-4/08/2003-

Dyax Corp. licenses antibody phase display technology and patent rights to ImClone Systems Inc. for therapeutic antibodies and disease diagnostics. To read article click here. Biotage Inc., a division of Dyax Corp., has a broad variety of purification systems for drug discovery. To find a review of Biotage's purification systems here at CombiChem Lab click here.

Study shows that combination of Ligand's Targretin® (bexarotene) with Taxol® (paclitaxel) prevents and overcomes taxol resistance both in vitro and in vivo. To read article click here.

Cytogen Corporation and DRAXIMAGE Inc. terminate agreements. To read article click here.

Archemix Corp. appoints Dr. Errol De Souza as President and CEO. To read article click here.

VistaGen Therapeutics Inc. and Sanwa Kagaku Kenkyusho Co. Ltd. form collaboration for stem cell based discovery tools. To read article click here.

AstraZeneca to buy DeCODE genetics Inc.'s RoboHTC automated protein crystallography platform. To read article click here.

-4/07/2003-

Press Release: ASINEX announces Multi-FTE Deal with Biovitrum. To read press release click here. ASINEX offers a large collection of highly pure and diverse small organic compounds for CombiChem and HTS as well as its services for chemistry and drug discovery. For a review of ASINEX's compound collections and services here at CombiChem Lab click here.

Press Release: Genevac Ltd has announced the introduction of a new and improved version of its successful Mega 980 Ultra High Throughput Evaporator for drug discovery applications. To read press release click here. Genevac Ltd. provides high-throughput centrifugal evaporation systems for combinatorial chemistry, high-throughput screening (HTS) and drug discovery. To read a review of Genevac's systems here at CombiChem Lab click here.

Press Release: ESA Analytical have introduced a new modular Evaporative Light Scattering Detector for use with HPLC that provides universal detection of non-volatile compounds. To read press release click here.

Bruker Daltonics Inc. and Bruker AXS Inc. to merge. To read article click here. Bruker AXS Inc. offers its D8 DISCOVER System for fast X-Ray diffraction screening analysis of combinatorial libraries. For a review on Bruker AXS's D8 DISCOVER System here at CombiChem Lab click here. Bruker Daltonics Inc. provides mass spectrometer systems for drug discovery applications. To read a review of Bruker Daltonics' Mass Spec systems here at CombiChem Lab click here.

The Strategic Research Institute (SRI) will host the "7th International Outsourcing of Pharmaceutical Chemistry & Biology" conference on September 22-23, 2003, in Cherry Hill, NJ. To read article click here. SRI promotes and hosts a broad range of scientific oriented conferences. For more information on SRI here at CombiChem Lab click here.

Applied Biosystems, HTS Biosystems Inc., and Mitsubishi Chemical Corporation sign distribution agreement for next-generation surface plasmon resonance (SPR) system. To read article click here. Applied Biosystems/MDS Sciex provides mass spectrometer systems for combinatorial chemistry and drug discovery. For a review of Applied Biosystems/MDS Sciex's systems here at CombiChem Lab click here.

CompleGen and Berlex Biosciences form drug discovery collaboration using CompleGen's XenoGene™ cell-based high-throughput assay system. To read article click here.

Aventis' patent for its blood thinner drug Lovenox challenged by unnamed company. To read article click here.

Thomson ISI ResearchSoft and Thieme Chemistry will include Science of Synthesis® publication style in EndNote®. To read article click here.

Chugai Pharma USA LLC appoints Dr. David J. Mazzo as President and CEO. To read article click here.

Researchers at CURIS Inc. publish in the journal The Proceedings of the National Academy of Sciences the identification of novel small molecule drug candidate CUR-61414 for the treatment of basal cell carcinoma. To read article click here.

CombiMatrix sales DNA Micorarray Synthesizer to Nihon Gene Research Laboratory. To read article click here.

Bio-Rad Laboratories Inc. receives FDA approval for Hepatitis B virus tests. To read article click here.

AviGenics Inc. appoints Dr.Yashwant Deo as President and CEO. To read article click here.

Protein Design Labs Inc. completes the acquisition of Eos Biotechnology Inc. To read article click here.

-4/04/2003-

Press Release: ASINEX Announces Lead Optimization Deal with Avalon Pharmaceuticals. To read press release click here. ASINEX offers a large collection of highly pure and diverse small organic compounds for CombiChem and HTS as well as its services for chemistry and drug discovery. For a review of ASINEX's compound collections and services here at CombiChem Lab click here.

The Strategic Research Institute (SRI) will host the "International Psychiatric Drug Discovery & Development" conference on June 23-24, 2003, in Princeton, NJ. To read article click here. SRI promotes and hosts a broad range of scientific oriented conferences. For more information on SRI here at CombiChem Lab click here.

FDA approves GeneSoft Pharmaceuticals Inc 's FACTIVE® (gemifloxacin) for the treatment of mild-to-moderate community-acquired pneumonia (CAP) and acute bacterial exacerbation of chronic bronchitis (AECB). To read article click here.

Aventis SA to settle Methionine lawsuit for $178 million. To read article click here.

Inex Pharmaceuticals to move its third anti-cancer drug for development. To read article click here.

Pfizer Inc's drug ziprasidone found to improve symptoms of acute mania in patients with bipolar disorder. To read article click here.

New study indicates ARICEPT® (donepezil HCl tablets) is highly effective in patients with severe Alzheimer's disease. To read article click here.

-4/03/2003-

ComGenex Inc. appoints Dr. Klaus Frobel as Executive Vice President of Medicinal Chemistry and Discovery Technologies. To read article click here. Comgenex Inc. provides services for the synthesis of drug-like compounds for high-throughput screening (HTS) and drug discovery. For a review of Comgenex Inc's services here at CombiChem Lab click here.

Pfizer Inc. to pay a $2 million award to a woman injured by the diabetes drug Rezulin. To read article click here.

Charles River Laboratories International Inc. and Proteome Systems Ltd. launch proteomic research service laboratory: Charles River Proteomic Services Inc. To read article click here.

King Pharmaceuticals Inc. backs away from $850 million deal with Elan Corp. To read article click here.

Xcyte Therapies Inc. begins Phase I/II clinical trial of its Xcellerated T Cells for multiple myeloma treatment. To read article click here.

Targeted Genetics Corp. to move its one-dose HIV/AIDS vaccine tgAAC09 to Phase I clinicals. To read article click here.

Access Pharmaceuticals Inc. moves its DACH Polymer Platinate compound AP5346 to Phase I clinical trials. To read article click here.

Biosyn Inc. acquires exclusive worldwide rights from the NIH for the novel protein cyanovirin-N as an HIV microbicide. To read article click here.

Palatin Technologies Inc. receives U.S. patent for PT-141 for the treatment of male and female sexual dysfunction. To read article click here.

Graffinity Pharmaceuticals AG and Serono S.A. enter research collaboration for several diseases. To read article click here.

-4/02/2003-

Tecan US launches its multimode microplate reader GENios Pro. To read article click here. Tecan provides the ChemSystem workstation and the TECAN MiniPrep systems for combinatorial chemistry and drug discovery. To read a review of TECAN's systems here at CombiChem Lab click here.

Rigel Pharmaceuticals Inc. reaches second milestone with Daiichi Pharmaceuticals Co. Ltd from collaboration targeting ligases for cancer treatment. To read article click here.

Erectile dysfunction may give early warning signs of cardiovascular disease. To read article click here.

Protein Pathways Inc. and Merck & Co. form drug discovery collaboration. To read article click here.

Akzo Nobel NV to cut another 60 jobs at its pharmaceutical unit Organon. To read article click here.

AstraZeneca's oral anticoagulant drug Exanta exhibits efficacy in stroke prevention. To read article click here.

Neuro Bioscience Inc. to acquire CLL Pharma S.A. To read article click here.

GlaxoSmithKline and Texas Biotechnology Corporation release study results of thrombin inhibitor Argatroban in combination with glycoprotein IIb/IIIa inhibitors. To read article click here.

Adolor Corp.'s alvimopan found effective and well-tolerated by patients with bowel dysfunction in Phase III clinical trial. To read article click here.

FDA approves GlaxoSmithKline's VALTREX® (valacyclovir HCl) caplets for recurrent genital herpes in HIV-infected individuals. To read article click here.

Celgene Corporation receives U.S. patent for polypeptides of mitogen-activated protein kinase kinases (MKKs) involved in the p38 and c-Jun N-terminal kinase (JNK) pathways. To read article click here.

Lorus Therapeutics Inc. receives 3rd U.S. patent for its anti-cancer product Virulizin. To read article click here.

Gene Logic Inc. completes the acquisition of TherImmune Research Corporation. To read article click here.

-4/01/2003-

Press Release: Porvair Sciences has announced the introduction of the ThermalBond™ Heat Sealer. To read press release click here.

The Strategic Research Institute (SRI) will host the 3rd International "Ion Channels in Drug Discovery and Development" conference on July 14-15, 2003, in Philadelphia, PA. To read article click here. SRI promotes and hosts a broad range of scientific oriented conferences. For more information on SRI here at CombiChem Lab click here.

The Strategic Research Institute (SRI) will host the "Growth Factor Receptors in Drug Discovery & Development" conference on May 5-6, 2003, in Philadelphia, PA. To read article click here. SRI promotes and hosts a broad range of scientific oriented conferences. For more information on SRI here at CombiChem Lab click here.

Varian Inc. introduces its new Interchangeable Flow Cell (IFC) accessory for its cold probes for their LC-NMR/MS instruments. To read article click here. Varian Inc. provides NMR instrumentation for research, including its Versatile Automated Sample Transport (VAST system) for combinatorial chemistry. For a review of Varian's NMR instrumentation for combinatorial chemistry here at CombiChem Lab click here.

LION bioscience AG releases its SRS version 7.1 platform for its DiscoveryCenter for life science R&D. To read article click here. LION offers its iDiscovery™ technologies and services for drug discovery. For a review of Lion's services here at CombiChem Lab click here.

Titan Pharmaceuticals Inc. posts positive results from two-year study of Spheramine for the treatment of Parkinson's disease. To read article click here.

Ligand Pharmaceuticals not to acquire X-Ceptor Therapeutics. To read article click here.

Pfizer Inc. and Daiichi Pharmaceutical Co. Ltd. enter R&D collaboration for active anti-infective agent against drug-resistant strains of bacteria. To read article click here.

Researchers from Progenics Pharmaceuticals discover first liver-specific receptor for Hepatitis C Virus (HCV). To read article click here.

ICN Pharmaceuticals Inc.'s nebulized version of Ribavirin gives positive results against severe acute respiratory syndrome (SARS). To read article click here.

Novartis AG's CEO announce no merger with Roche Holding AG in the near future. To read article click here.

De Novo Pharmaceuticals and Peakdale Molecular form collaboration for drug design and synthesis. To read article click here.

The New Jersey Nanotechnology Consortium (NJNC) begins business operations. To read article click here.